A single injection just replaced a $1 million procedure.


Traditional CAR-T therapy costs over $1 million and takes weeks. Doctors extract your T-cells, re-engineer them in a lab to recognize cancer, then reinfuse them.
Researchers are now doing the same thing with a single injection.
It's called in vivo CAR-T. Lipid nanoparticles carry genetic instructions directly into your bloodstream.
They find your T-cells, fuse with them, and deliver the gene for a cancer-targeting receptor.
The T-cells build the receptor themselves. No extraction. No bioreactor. No weeks of waiting.
The platform is already in clinical trials targeting blood cancers including B-cell lymphoma and leukemia.
The same lipid nanoparticle technology that delivered COVID mRNA vaccines is now being used to reprogram your immune system to hunt cancer.
post-image
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin